0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Influenza Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
Published Date: July 2021
|
Report Code: QYRE-Othe-4139
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Influenza Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

Global Influenza Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Code: QYRE-Othe-4139
Report
July 2021
115 Pages
QYResearch
Region: North America, Asia Pacific, Europe, South America, Africa, Middle East, Global,
Description
Table of Content
Tables & Figures
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Global Influenza Vaccine main players include CSL, GSK, Sanofi Pasteur, Mylan, Hulan Bio, AstraZeneca, CCBIO, etc., totally accounting for about 95% of market. North America is the largest market of Influenza Vaccine, with a share over 55%. As for the types of products, it can be divided into Trivalent Influenza Vaccine and Quadrivalent Influenza Vaccine. The most common product is Quadrivalent Influenza Vaccine, with a share over 95%. In terms of applications, it is widely used in For Children (6 months to 3 years) and For Adults and Children over 3 years. The most application is in Adults and Children over 3 years, with a share over 73%.
 
Market Analysis and Insights: Global Influenza Vaccine Market

In 2020, the global Influenza Vaccine market size was US$ 5154 million and it is expected to reach US$ 6867 million by the end of 2027, with a CAGR of 3.8% during 2021-2027.

Global Influenza Vaccine Scope and Market Size
Influenza Vaccine market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Influenza Vaccine market is segmented into

  • Trivalent Influenza Vaccine
  • Quadrivalent Influenza Vaccine

Segment by Application, the Influenza Vaccine market is segmented into

  • For Children (6 months to 3 years)
  • For Adults and Children over 3 years
Regional and Country-level Analysis:
  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Australia
  • Rest of Asia-Pacific
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA
 
Competitive Landscape and Influenza Vaccine Market Share Analysis
Influenza Vaccine market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Influenza Vaccine product introduction, recent developments, Influenza Vaccine sales by region, type, application and by sales channel.
 
The major companies include:
  • CSL
  • GSK
  • Sanofi Pasteur
  • Mylan
  • Hulan Bio
  • AstraZeneca
  • CCBIO
1 Study Coverage
1.1 Influenza Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Influenza Vaccine Market Size Growth Rate by Type
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Market by Application
1.3.1 Global Influenza Vaccine Market Size Growth Rate by Application
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Influenza Vaccine Market Size Estimates and Forecasts
2.1.1 Global Influenza Vaccine Revenue 2016-2027
2.1.2 Global Influenza Vaccine Sales 2016-2027
2.2 Influenza Vaccine Market Size by Region: 2021 Versus 2027
2.3 Influenza Vaccine Sales by Region (2016-2027)
2.3.1 Global Influenza Vaccine Sales by Region: 2016-2021
2.3.2 Global Influenza Vaccine Sales Forecast by Region (2022-2027)
2.3.3 Global Influenza Vaccine Sales Market Share by Region (2016-2027)
2.4 Influenza Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Influenza Vaccine Revenue by Region: 2016-2021
2.4.2 Global Influenza Vaccine Revenue Forecast by Region (2022-2027)
2.4.3 Global Influenza Vaccine Revenue Market Share by Region (2016-2027)
3 Global Influenza Vaccine by Manufacturers
3.1 Global Top Influenza Vaccine Manufacturers by Sales
3.1.1 Global Influenza Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Influenza Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Influenza Vaccine Manufacturers by Revenue
3.2.1 Global Influenza Vaccine Revenue by Manufacturer (2016-2021)
3.2.2 Global Influenza Vaccine Revenue Share by Manufacturer (2016-2021)
3.3 Global Influenza Vaccine Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Influenza Vaccine Manufacturers Covered: Ranking by Revenue
3.4.2 Global Influenza Vaccine Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Influenza Vaccine Manufacturing Base Distribution, Product Type
3.5.1 Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Influenza Vaccine Product Type
3.5.3 Date of International Manufacturers Enter into Influenza Vaccine Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 CSL
4.1.1 CSL Corporation Information
4.1.2 CSL Description, Business Overview
4.1.3 CSL Influenza Vaccine Products Offered
4.1.4 CSL Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.1.5 CSL Influenza Vaccine Revenue by Product
4.1.6 CSL Influenza Vaccine Revenue by Application
4.1.7 CSL Influenza Vaccine Revenue by Geographic Area
4.1.8 CSL Influenza Vaccine Revenue by Sales Channel
4.1.9 CSL Recent Development
4.2 GSK
4.2.1 GSK Corporation Information
4.2.2 GSK Description, Business Overview
4.2.3 GSK Influenza Vaccine Products Offered
4.2.4 GSK Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.2.5 GSK Influenza Vaccine Revenue by Product
4.2.6 GSK Influenza Vaccine Revenue by Application
4.2.7 GSK Influenza Vaccine Revenue by Geographic Area
4.2.8 GSK Influenza Vaccine Revenue by Sales Channel
4.2.9 GSK Recent Development
4.3 Sanofi Pasteur
4.3.1 Sanofi Pasteur Corporation Information
4.3.2 Sanofi Pasteur Description, Business Overview
4.3.3 Sanofi Pasteur Influenza Vaccine Products Offered
4.3.4 Sanofi Pasteur Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.3.5 Sanofi Pasteur Influenza Vaccine Revenue by Product
4.3.6 Sanofi Pasteur Influenza Vaccine Revenue by Application
4.3.7 Sanofi Pasteur Influenza Vaccine Revenue by Geographic Area
4.3.8 Sanofi Pasteur Influenza Vaccine Revenue by Sales Channel
4.3.9 Sanofi Pasteur Recent Development
4.4 Mylan
4.4.1 Mylan Corporation Information
4.4.2 Mylan Description, Business Overview
4.4.3 Mylan Influenza Vaccine Products Offered
4.4.4 Mylan Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.4.5 Mylan Influenza Vaccine Revenue by Product
4.4.6 Mylan Influenza Vaccine Revenue by Application
4.4.7 Mylan Influenza Vaccine Revenue by Geographic Area
4.4.8 Mylan Influenza Vaccine Revenue by Sales Channel
4.4.9 Mylan Recent Development
4.5 Hulan Bio
4.5.1 Hulan Bio Corporation Information
4.5.2 Hulan Bio Description, Business Overview
4.5.3 Hulan Bio Influenza Vaccine Products Offered
4.5.4 Hulan Bio Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.5.5 Hulan Bio Influenza Vaccine Revenue by Product
4.5.6 Hulan Bio Influenza Vaccine Revenue by Application
4.5.7 Hulan Bio Influenza Vaccine Revenue by Geographic Area
4.5.8 Hulan Bio Influenza Vaccine Revenue by Sales Channel
4.5.9 Hulan Bio Recent Development
4.6 AstraZeneca
4.6.1 AstraZeneca Corporation Information
4.6.2 AstraZeneca Description, Business Overview
4.6.3 AstraZeneca Influenza Vaccine Products Offered
4.6.4 AstraZeneca Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.6.5 AstraZeneca Influenza Vaccine Revenue by Product
4.6.6 AstraZeneca Influenza Vaccine Revenue by Application
4.6.7 AstraZeneca Influenza Vaccine Revenue by Geographic Area
4.6.8 AstraZeneca Recent Development
4.7 CCBIO
4.7.1 CCBIO Corporation Information
4.7.2 CCBIO Description, Business Overview
4.7.3 CCBIO Influenza Vaccine Products Offered
4.7.4 CCBIO Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.7.5 CCBIO Influenza Vaccine Revenue by Product
4.7.6 CCBIO Influenza Vaccine Revenue by Application
4.7.7 CCBIO Influenza Vaccine Revenue by Geographic Area
4.7.8 CCBIO Recent Development
5 Breakdown Data by Type
5.1 Global Influenza Vaccine Sales by Type (2016-2027)
5.1.1 Global Influenza Vaccine Sales by Type (2016-2021)
5.1.2 Global Influenza Vaccine Sales Forecast by Type (2022-2027)
5.1.3 Global Influenza Vaccine Sales Market Share by Type (2016-2027)
5.2 Global Influenza Vaccine Revenue Forecast by Type (2016-2027)
5.2.1 Global Influenza Vaccine Revenue by Type (2016-2021)
5.2.2 Global Influenza Vaccine Revenue Forecast by Type (2022-2027)
5.2.3 Global Influenza Vaccine Revenue Market Share by Type (2016-2027)
5.3 Influenza Vaccine Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Influenza Vaccine Sales by Application (2016-2027)
6.1.1 Global Influenza Vaccine Sales by Application (2016-2021)
6.1.2 Global Influenza Vaccine Sales Forecast by Application (2022-2027)
6.1.3 Global Influenza Vaccine Sales Market Share by Application (2016-2027)
6.2 Global Influenza Vaccine Revenue Forecast by Application (2016-2027)
6.2.1 Global Influenza Vaccine Revenue by Application (2016-2021)
6.2.2 Global Influenza Vaccine Revenue Forecast by Application (2022-2027)
6.2.3 Global Influenza Vaccine Revenue Market Share by Application (2016-2027)
6.3 Influenza Vaccine Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Influenza Vaccine Market Size YoY Growth 2016-2027
7.2 North America Influenza Vaccine Market Facts & Figures by Country
7.2.1 North America Influenza Vaccine Sales by Country (2016-2027)
7.2.2 North America Influenza Vaccine Revenue by Country (2016-2027)
7.3 North America Influenza Vaccine Sales by Type
7.4 North America Influenza Vaccine Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Influenza Vaccine Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Influenza Vaccine Market Facts & Figures by Region
8.2.1 Asia-Pacific Influenza Vaccine Sales by Region (2016-2027)
8.2.2 Asia-Pacific Influenza Vaccine Revenue by Region (2016-2027)
8.3 Asia-Pacific Influenza Vaccine Sales by Type
8.4 Asia-Pacific Influenza Vaccine Sales by Application
9 Europe
9.1 Europe Influenza Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Influenza Vaccine Market Facts & Figures by Country
9.2.1 Europe Influenza Vaccine Sales by Country (2016-2027)
9.2.2 Europe Influenza Vaccine Revenue by Country (2016-2027)
9.3 Europe Influenza Vaccine Sales by Type
9.4 Europe Influenza Vaccine Sales by Application
10 Latin America
10.1 Latin America Influenza Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Influenza Vaccine Market Facts & Figures by Country
10.2.1 Latin America Influenza Vaccine Sales by Country (2016-2027)
10.2.2 Latin America Influenza Vaccine Revenue by Country (2016-2027)
10.3 Latin America Influenza Vaccine Sales by Type
10.4 Latin America Influenza Vaccine Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Influenza Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Influenza Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Influenza Vaccine Sales by Country (2016-2027)
11.2.2 Middle East and Africa Influenza Vaccine Revenue by Country (2016-2027)
11.3 Middle East and Africa Influenza Vaccine Sales by Type
11.4 Middle East and Africa Influenza Vaccine Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Influenza Vaccine Supply Chain Analysis
12.2 Influenza Vaccine Key Raw Materials and Upstream Suppliers
12.3 Influenza Vaccine Clients Analysis
12.4 Influenza Vaccine Sales Channel and Sales Model Analysis
12.4.1 Influenza Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Influenza Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Influenza Vaccine Distributors
13 Market Dynamics
13.1 Influenza Vaccine Market Drivers
13.2 Influenza Vaccine Market Opportunities
13.3 Influenza Vaccine Market Challenges
13.4 Influenza Vaccine Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Influenza Vaccine Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
    Table 2. Major Manufacturers of Trivalent Influenza Vaccine
    Table 3. Major Manufacturers of Quadrivalent Influenza Vaccine
    Table 4. Global Influenza Vaccine Market Size Growth by Application (US$ Million): 2021 VS 2027
    Table 5. Global Influenza Vaccine Market Size by Region (US$ Million): 2021 VS 2027
    Table 6. Global Influenza Vaccine Sales by Region (2016-2021) & (M Doses)
    Table 7. Global Influenza Vaccine Sales Forecast by Region (2022-2027) & (M Doses)
    Table 8. Global Influenza Vaccine Revenue by Region (2016-2021) & (US$ Million)
    Table 9. Global Influenza Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 10. Global Influenza Vaccine Sales by Manufacturer (2016-2021) & (M Doses)
    Table 11. Global Influenza Vaccine Sales Share by Manufacturer (2016-2021)
    Table 12. Influenza Vaccine Revenue by Manufacturer (2016-2021) & (US$ Million)
    Table 13. Influenza Vaccine Revenue Share by Manufacturer (2016-2021)
    Table 14. Key Manufacturers Influenza Vaccine Price (2016-2021) & (USD/Doses)
    Table 15. Ranking of Global Top Influenza Vaccine Manufacturers by Revenue (US$ Million) in 2020
    Table 16. Global Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 17. Global Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Vaccine as of 2020)
    Table 18. Influenza Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
    Table 19. Manufacturers Influenza Vaccine Product Type
    Table 20. Date of International Manufacturers Enter into Influenza Vaccine Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. CSL Corporation Information
    Table 23. CSL Description and Business Overview
    Table 24. CSL Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
    Table 25. CSL Influenza Vaccine Product
    Table 26. CSL Influenza Vaccine Revenue (US$ Million) and Market Share by Product
    Table 27. CSL Influenza Vaccine Revenue (US$ Million) and Market Share by Application
    Table 28. CSL Influenza Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 29. CSL Influenza Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 30. CSL Recent Development
    Table 31. GSK Corporation Information
    Table 32. GSK Description and Business Overview
    Table 33. GSK Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
    Table 34. GSK Influenza Vaccine Product
    Table 35. GSK Influenza Vaccine Revenue (US$ Million) and Market Share by Product
    Table 36. GSK Influenza Vaccine Revenue (US$ Million) and Market Share by Application
    Table 37. GSK Influenza Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 38. GSK Influenza Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 39. GSK Recent Development
    Table 40. Sanofi Pasteur Corporation Information
    Table 41. Sanofi Pasteur Description and Business Overview
    Table 42. Sanofi Pasteur Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
    Table 43. Sanofi Pasteur Influenza Vaccine Product
    Table 44. Sanofi Pasteur Influenza Vaccine Revenue (US$ Million) and Market Share by Product
    Table 45. Sanofi Pasteur Influenza Vaccine Revenue (US$ Million) and Market Share by Application
    Table 46. Sanofi Pasteur Influenza Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 47. Sanofi Pasteur Influenza Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 48. Sanofi Pasteur Recent Development
    Table 49. Mylan Corporation Information
    Table 50. Mylan Description and Business Overview
    Table 51. Mylan Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
    Table 52. Mylan Influenza Vaccine Product
    Table 53. Mylan Influenza Vaccine Revenue (US$ Million) and Market Share by Product
    Table 54. Mylan Influenza Vaccine Revenue (US$ Million) and Market Share by Application
    Table 55. Mylan Influenza Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 56. Mylan Influenza Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 57. Mylan Recent Development
    Table 58. Hulan Bio Corporation Information
    Table 59. Hulan Bio Description and Business Overview
    Table 60. Hulan Bio Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
    Table 61. Hulan Bio Influenza Vaccine Product
    Table 62. Hulan Bio Influenza Vaccine Revenue (US$ Million) and Market Share by Product
    Table 63. Hulan Bio Influenza Vaccine Revenue (US$ Million) and Market Share by Application
    Table 64. Hulan Bio Influenza Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 65. Hulan Bio Influenza Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 66. Hulan Bio Recent Development
    Table 67. AstraZeneca Corporation Information
    Table 68. AstraZeneca Description and Business Overview
    Table 69. AstraZeneca Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
    Table 70. AstraZeneca Influenza Vaccine Product
    Table 71. AstraZeneca Influenza Vaccine Revenue (US$ Million) and Market Share by Product
    Table 72. AstraZeneca Influenza Vaccine Revenue (US$ Million) and Market Share by Application
    Table 73. AstraZeneca Influenza Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 74. AstraZeneca Recent Development
    Table 75. CCBIO Corporation Information
    Table 76. CCBIO Description and Business Overview
    Table 77. CCBIO Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
    Table 78. CCBIO Influenza Vaccine Product
    Table 79. CCBIO Influenza Vaccine Revenue (US$ Million) and Market Share by Product
    Table 80. CCBIO Influenza Vaccine Revenue (US$ Million) and Market Share by Application
    Table 81. CCBIO Influenza Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 82. CCBIO Recent Development
    Table 83. Global Influenza Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 84. Global Influenza Vaccine Sales Forecast by Type (2022-2027) & (M Doses)
    Table 85. Global Influenza Vaccine Revenue by Type (2016-2021) & (US$ Million)
    Table 86. Global Influenza Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 87. Global Influenza Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 88. Global Influenza Vaccine Sales Forecast by Application (2022-2027) & (M Doses)
    Table 89. Global Influenza Vaccine Revenue by Application (2016-2021) & (US$ Million)
    Table 90. Global Influenza Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 91. North America Influenza Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 92. North America Influenza Vaccine Sales by Country (2022-2027) & (M Doses)
    Table 93. North America Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 94. North America Influenza Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 95. North America Influenza Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 96. North America Influenza Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 97. Asia-Pacific Influenza Vaccine Sales by Region (2016-2021) & (M Doses)
    Table 98. Asia-Pacific Influenza Vaccine Sales by Region (2022-2027) & (M Doses)
    Table 99. Asia-Pacific Influenza Vaccine Revenue by Region (2016-2027) & (US$ Million)
    Table 100. Asia-Pacific Influenza Vaccine Revenue by Region (2022-2027) & (US$ Million)
    Table 101. Asia-Pacific Influenza Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 102. Asia-Pacific Influenza Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 103. Europe Influenza Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 104. Europe Influenza Vaccine Sales by Country (2022-2027) & (M Doses)
    Table 105. Europe Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 106. Europe Influenza Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 107. Europe Influenza Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 108. Europe Influenza Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 109. Latin America Influenza Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 110. Latin America Influenza Vaccine Sales by Country (2022-2027) & (M Doses)
    Table 111. Latin America Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 112. Latin America Influenza Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 113. Latin America Influenza Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 114. Latin America Influenza Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 115. Middle East and Africa Influenza Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 116. Middle East and Africa Influenza Vaccine Sales by Country (2022-2027) & (M Doses)
    Table 117. Middle East and Africa Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 118. Middle East and Africa Influenza Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 119. Middle East and Africa Influenza Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 120. Middle East and Africa Influenza Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 121. Influenza Vaccine Key Raw Materials, Industry Status and Trend
    Table 122. Influenza Vaccine Key Raw Materials and Upstream Suppliers
    Table 123. Influenza Vaccine Clients Status and Trend
    Table 124. Influenza Vaccine Typical Clients
    Table 125. Influenza Vaccine Distributors
    Table 126. Key Drivers: Impact Analysis (2022-2027)
    Table 127. Influenza Vaccine Market Drivers
    Table 128. Influenza Vaccine Market Opportunities
    Table 129. Influenza Vaccine Market Challenges
    Table 130. Influenza Vaccine Market Restraints
    Table 131. Influenza Vaccine Porter’s Five Forces Analysis
    Table 132. Research Programs/Design for This Report
    Table 133. Key Data Information from Secondary Sources
    Table 134. Key Data Information from Primary Sources
List of Figures
    Figure 1. Influenza Vaccine Product Picture
    Figure 2. Global Influenza Vaccine Sales Market Share by Type in 2021 & 2027
    Figure 3. Trivalent Influenza Vaccine Product Picture
    Figure 4. Quadrivalent Influenza Vaccine Product Picture
    Figure 5. Global Influenza Vaccine Sales Market Share by Application in 2021 & 2027
    Figure 6. For Children (6 months to 3 years) Examples
    Figure 7. For Adults and Children over 3 years Examples
    Figure 8. Influenza Vaccine Report Years Considered
    Figure 9. Global Influenza Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Influenza Vaccine Market Size 2016-2027 (US$ Million)
    Figure 11. Global Influenza Vaccine Sales 2016-2027 (K Units)
    Figure 12. Global Influenza Vaccine Market Size Market Share by Region: 2021 Versus 2027
    Figure 13. Global Influenza Vaccine Sales Market Share Forecast by Region (2016-2027)
    Figure 14. Global Influenza Vaccine Revenue Market Share by Region (2016-2027)
    Figure 15. Global Influenza Vaccine Sales Share by Manufacturer in 2020
    Figure 16. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 17. Global Influenza Vaccine Sales Market Share Forecast by Type (2016-2027)
    Figure 18. Global Influenza Vaccine Revenue Market Share Forecast by Type (2016-2027)
    Figure 19. Influenza Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
    Figure 20. Global Influenza Vaccine Sales Market Share Forecast by Application (2016-2027)
    Figure 21. Global Influenza Vaccine Revenue Market Share Forecast by Application (2016-2027)
    Figure 22. Influenza Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
    Figure 23. North America Influenza Vaccine Revenue 2016-2027 (US$ Million)
    Figure 24. North America Influenza Vaccine Sales Market Share by Type (2016-2021)
    Figure 25. North America Influenza Vaccine Sales Market Share by Application (2016-2021)
    Figure 26. Asia-Pacific Influenza Vaccine Revenue 2016-2027 (US$ Million)
    Figure 27. Asia-Pacific Influenza Vaccine Sales Market Share by Region (2016-2027)
    Figure 28. Asia-Pacific Influenza Vaccine Revenue Market Share by Region (2016-2027)
    Figure 29. Asia-Pacific Influenza Vaccine Sales Market Share by Type (2016-2021)
    Figure 30. Asia-Pacific Influenza Vaccine Sales Market Share by Application (2016-2021)
    Figure 31. Europe Influenza Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 32. Europe Influenza Vaccine Sales Market Share by Country (2016-2027)
    Figure 33. Europe Influenza Vaccine Revenue Market Share by Country (2016-2027)
    Figure 34. Europe Influenza Vaccine Sales Market Share by Type (2016-2021)
    Figure 35. Europe Influenza Vaccine Sales Market Share by Application (2016-2021)
    Figure 36. Latin America Influenza Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 37. Latin America Influenza Vaccine Sales Market Share by Country (2016-2027)
    Figure 38. Latin America Influenza Vaccine Revenue Market Share by Country (2016-2021)
    Figure 39. Latin America Influenza Vaccine Sales Market Share by Type (2016-2021)
    Figure 40. Latin America Influenza Vaccine Sales Market Share by Application (2016-2021)
    Figure 41. Middle East and Africa Influenza Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 42. Middle East and Africa Influenza Vaccine Sales Market Share by Country (2016-2027)
    Figure 43. Middle East and Africa Influenza Vaccine Revenue Market Share by Country (2016-2027)
    Figure 44. Middle East and Africa Influenza Vaccine Sales Market Share by Type (2016-2021)
    Figure 45. Middle East and Africa Influenza Vaccine Sales Market Share by Application (2016-2021)
    Figure 46. Influenza Vaccine Supply Chain (Upstream and Downstream Market)
    Figure 47. Global Production Market Share of Influenza Vaccine Raw Materials by Region in 2020
    Figure 48. Influenza Vaccine Distribution Channels
    Figure 49. Global Influenza Vaccine Percentage 2016-2027: Indirect Sales VS Direct Sales
    Figure 50. Global Influenza Vaccine Percentage 2016-2027: Online Sales VS Offline Sales
    Figure 51. Porter's Five Forces Analysis
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user to access the PDF.

Electronic (PDF)
$8850
This license allows multiple user to access the PDF.

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SIS Group of Schools

RELATED REPORTS

Global and China Mycobacterium Tuberculosis Antibodies Market Insights Forecast to 2027
Global and China Mycobacterium Tuberculosis Antibodies Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-15D7777
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and China Escherichia Coli Antibody Market Insights Forecast to 2027
Global and China Escherichia Coli Antibody Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-20G7629
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and United States Chlamydia Trachomatis Antibodies Market Insights Forecast to 2027
Global and United States Chlamydia Trachomatis Antibodies Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-21F7760
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and China Prophylactic HIV Drug Market Insights Forecast to 2027
Global and China Prophylactic HIV Drug Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-7T7637
Sun Nov 21 00:00:00 UTC 2021

Add to Cart